AmSurg Downgraded To Neutral
Recently, we downgraded AmSurg Corporation (NASDAQ:AMSG) to Neutral with a target price of $27.00. In the face of headwinds such as reimbursement issues, higher expenses and tax rate, AmSurg missed the Zacks Consensus Estimate on both the EPS and revenue front. During the quarter, AmSurg reported EPS of $0.42, missing the Zacks Consensus Estimate by [...]
Recently, we downgraded AmSurg Corporation (NASDAQ:AMSG) to Neutral with a target price of $27.00.
In the face of headwinds such as reimbursement issues, higher expenses and tax rate, AmSurg missed the Zacks Consensus Estimate on both the EPS and revenue front. During the quarter, AmSurg reported EPS of $0.42, missing the Zacks Consensus Estimate by $0.01. Although revenues increased 11% year over year to $195.9 million, it was below the Zacks Consensus Estimate of $200 million.
Challenges such as … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards